nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—ACHE—prostate cancer	0.503	1	CbGaD
Neostigmine—ABCB1—Estramustine—prostate cancer	0.0559	0.2	CbGbCtD
Neostigmine—ABCB1—Cabazitaxel—prostate cancer	0.0368	0.132	CbGbCtD
Neostigmine—ABCB1—Estrone—prostate cancer	0.036	0.129	CbGbCtD
Neostigmine—ABCB1—Ethinyl Estradiol—prostate cancer	0.0321	0.115	CbGbCtD
Neostigmine—ABCB1—Conjugated Estrogens—prostate cancer	0.0236	0.0843	CbGbCtD
Neostigmine—ABCB1—Mitoxantrone—prostate cancer	0.0214	0.0767	CbGbCtD
Neostigmine—ABCB1—Estradiol—prostate cancer	0.0207	0.074	CbGbCtD
Neostigmine—ABCB1—Prednisone—prostate cancer	0.0178	0.0637	CbGbCtD
Neostigmine—ABCB1—Etoposide—prostate cancer	0.0135	0.0483	CbGbCtD
Neostigmine—ABCB1—Docetaxel—prostate cancer	0.0124	0.0442	CbGbCtD
Neostigmine—ABCB1—Doxorubicin—prostate cancer	0.00921	0.033	CbGbCtD
Neostigmine—Demecarium—ACHE—prostate cancer	0.00206	0.337	CrCbGaD
Neostigmine—Pyridostigmine—ACHE—prostate cancer	0.00133	0.217	CrCbGaD
Neostigmine—Edrophonium—ACHE—prostate cancer	0.00108	0.177	CrCbGaD
Neostigmine—Rivastigmine—ACHE—prostate cancer	0.00101	0.164	CrCbGaD
Neostigmine—Pyridostigmine—CYP3A4—prostate cancer	0.000368	0.06	CrCbGaD
Neostigmine—Rivastigmine—CYP3A4—prostate cancer	0.000279	0.0455	CrCbGaD
Neostigmine—Dizziness—Goserelin—prostate cancer	0.000128	0.000873	CcSEcCtD
Neostigmine—Dyspnoea—Mitoxantrone—prostate cancer	0.000128	0.000869	CcSEcCtD
Neostigmine—Somnolence—Mitoxantrone—prostate cancer	0.000127	0.000867	CcSEcCtD
Neostigmine—Dizziness—Conjugated Estrogens—prostate cancer	0.000127	0.000865	CcSEcCtD
Neostigmine—Convulsion—Etoposide—prostate cancer	0.000127	0.000861	CcSEcCtD
Neostigmine—Osteoarthritis—Doxorubicin—prostate cancer	0.000126	0.000856	CcSEcCtD
Neostigmine—Gastrointestinal pain—Estradiol—prostate cancer	0.000126	0.000856	CcSEcCtD
Neostigmine—Mediastinal disorder—Docetaxel—prostate cancer	0.000126	0.000855	CcSEcCtD
Neostigmine—Flushing—Capecitabine—prostate cancer	0.000125	0.000853	CcSEcCtD
Neostigmine—Arrhythmia—Docetaxel—prostate cancer	0.000125	0.000848	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000124	0.00084	CcSEcCtD
Neostigmine—Vomiting—Goserelin—prostate cancer	0.000123	0.000839	CcSEcCtD
Neostigmine—Bradycardia—Prednisone—prostate cancer	0.000122	0.000833	CcSEcCtD
Neostigmine—Rash—Goserelin—prostate cancer	0.000122	0.000832	CcSEcCtD
Neostigmine—Dermatitis—Goserelin—prostate cancer	0.000122	0.000832	CcSEcCtD
Neostigmine—Vomiting—Conjugated Estrogens—prostate cancer	0.000122	0.000831	CcSEcCtD
Neostigmine—Urticaria—Estradiol—prostate cancer	0.000122	0.000831	CcSEcCtD
Neostigmine—Mental disorder—Docetaxel—prostate cancer	0.000122	0.000831	CcSEcCtD
Neostigmine—Mediastinal disorder—Capecitabine—prostate cancer	0.000122	0.000828	CcSEcCtD
Neostigmine—Abdominal pain—Estradiol—prostate cancer	0.000122	0.000827	CcSEcCtD
Neostigmine—Headache—Goserelin—prostate cancer	0.000122	0.000827	CcSEcCtD
Neostigmine—Rash—Conjugated Estrogens—prostate cancer	0.000121	0.000825	CcSEcCtD
Neostigmine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000121	0.000824	CcSEcCtD
Neostigmine—Arrhythmia—Capecitabine—prostate cancer	0.000121	0.000821	CcSEcCtD
Neostigmine—Headache—Conjugated Estrogens—prostate cancer	0.00012	0.000819	CcSEcCtD
Neostigmine—Cardiac arrest—Doxorubicin—prostate cancer	0.00012	0.000814	CcSEcCtD
Neostigmine—Anaphylactic shock—Etoposide—prostate cancer	0.000119	0.000811	CcSEcCtD
Neostigmine—Mental disorder—Capecitabine—prostate cancer	0.000118	0.000805	CcSEcCtD
Neostigmine—Connective tissue disorder—Prednisone—prostate cancer	0.000118	0.000804	CcSEcCtD
Neostigmine—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000117	0.000797	CcSEcCtD
Neostigmine—Muscle spasms—Docetaxel—prostate cancer	0.000117	0.000794	CcSEcCtD
Neostigmine—Tachycardia—Etoposide—prostate cancer	0.000116	0.000792	CcSEcCtD
Neostigmine—Flatulence—Capecitabine—prostate cancer	0.000116	0.000788	CcSEcCtD
Neostigmine—Skin disorder—Etoposide—prostate cancer	0.000116	0.000788	CcSEcCtD
Neostigmine—Nausea—Goserelin—prostate cancer	0.000115	0.000784	CcSEcCtD
Neostigmine—Hyperhidrosis—Etoposide—prostate cancer	0.000115	0.000784	CcSEcCtD
Neostigmine—Nausea—Conjugated Estrogens—prostate cancer	0.000114	0.000777	CcSEcCtD
Neostigmine—Urticaria—Mitoxantrone—prostate cancer	0.000114	0.000775	CcSEcCtD
Neostigmine—Hypersensitivity—Estradiol—prostate cancer	0.000113	0.000771	CcSEcCtD
Neostigmine—Abdominal pain—Mitoxantrone—prostate cancer	0.000113	0.000771	CcSEcCtD
Neostigmine—Muscle spasms—Capecitabine—prostate cancer	0.000113	0.000769	CcSEcCtD
Neostigmine—Flushing—Prednisone—prostate cancer	0.000112	0.000759	CcSEcCtD
Neostigmine—Hypotension—Etoposide—prostate cancer	0.000111	0.000758	CcSEcCtD
Neostigmine—Asthenia—Estradiol—prostate cancer	0.00011	0.000751	CcSEcCtD
Neostigmine—Syncope—Docetaxel—prostate cancer	0.000109	0.000741	CcSEcCtD
Neostigmine—Pruritus—Estradiol—prostate cancer	0.000109	0.00074	CcSEcCtD
Neostigmine—Pollakiuria—Epirubicin—prostate cancer	0.000109	0.000739	CcSEcCtD
Neostigmine—Arrhythmia—Prednisone—prostate cancer	0.000107	0.000731	CcSEcCtD
Neostigmine—Loss of consciousness—Docetaxel—prostate cancer	0.000107	0.000726	CcSEcCtD
Neostigmine—Dyspnoea—Etoposide—prostate cancer	0.000106	0.000723	CcSEcCtD
Neostigmine—Somnolence—Etoposide—prostate cancer	0.000106	0.000721	CcSEcCtD
Neostigmine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000106	0.000718	CcSEcCtD
Neostigmine—Syncope—Capecitabine—prostate cancer	0.000105	0.000717	CcSEcCtD
Neostigmine—Mental disorder—Prednisone—prostate cancer	0.000105	0.000717	CcSEcCtD
Neostigmine—Diarrhoea—Estradiol—prostate cancer	0.000105	0.000716	CcSEcCtD
Neostigmine—Convulsion—Docetaxel—prostate cancer	0.000105	0.000716	CcSEcCtD
Neostigmine—Drowsiness—Epirubicin—prostate cancer	0.000105	0.000713	CcSEcCtD
Neostigmine—Arthralgia—Docetaxel—prostate cancer	0.000103	0.000703	CcSEcCtD
Neostigmine—Loss of consciousness—Capecitabine—prostate cancer	0.000103	0.000703	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Etoposide—prostate cancer	0.000103	0.0007	CcSEcCtD
Neostigmine—Asthenia—Mitoxantrone—prostate cancer	0.000103	0.0007	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000103	0.000698	CcSEcCtD
Neostigmine—Dizziness—Estradiol—prostate cancer	0.000102	0.000692	CcSEcCtD
Neostigmine—Dry mouth—Docetaxel—prostate cancer	0.000101	0.000688	CcSEcCtD
Neostigmine—Pollakiuria—Doxorubicin—prostate cancer	0.0001	0.000683	CcSEcCtD
Neostigmine—Arthralgia—Capecitabine—prostate cancer	0.0001	0.000681	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	9.94e-05	0.000676	CcSEcCtD
Neostigmine—Anaphylactic shock—Docetaxel—prostate cancer	9.91e-05	0.000674	CcSEcCtD
Neostigmine—Diarrhoea—Mitoxantrone—prostate cancer	9.81e-05	0.000667	CcSEcCtD
Neostigmine—Dry mouth—Capecitabine—prostate cancer	9.79e-05	0.000666	CcSEcCtD
Neostigmine—Vomiting—Estradiol—prostate cancer	9.78e-05	0.000665	CcSEcCtD
Neostigmine—Gastrointestinal pain—Etoposide—prostate cancer	9.75e-05	0.000663	CcSEcCtD
Neostigmine—Shock—Docetaxel—prostate cancer	9.75e-05	0.000663	CcSEcCtD
Neostigmine—Nervous system disorder—Docetaxel—prostate cancer	9.72e-05	0.000661	CcSEcCtD
Neostigmine—Rash—Estradiol—prostate cancer	9.7e-05	0.00066	CcSEcCtD
Neostigmine—Drowsiness—Doxorubicin—prostate cancer	9.7e-05	0.00066	CcSEcCtD
Neostigmine—Dermatitis—Estradiol—prostate cancer	9.69e-05	0.000659	CcSEcCtD
Neostigmine—Tachycardia—Docetaxel—prostate cancer	9.67e-05	0.000658	CcSEcCtD
Neostigmine—Headache—Estradiol—prostate cancer	9.64e-05	0.000656	CcSEcCtD
Neostigmine—Skin disorder—Docetaxel—prostate cancer	9.63e-05	0.000655	CcSEcCtD
Neostigmine—Agitation—Prednisone—prostate cancer	9.63e-05	0.000655	CcSEcCtD
Neostigmine—Bradycardia—Epirubicin—prostate cancer	9.58e-05	0.000652	CcSEcCtD
Neostigmine—Urticaria—Etoposide—prostate cancer	9.47e-05	0.000644	CcSEcCtD
Neostigmine—Shock—Capecitabine—prostate cancer	9.44e-05	0.000642	CcSEcCtD
Neostigmine—Abdominal pain—Etoposide—prostate cancer	9.43e-05	0.000641	CcSEcCtD
Neostigmine—Nervous system disorder—Capecitabine—prostate cancer	9.41e-05	0.00064	CcSEcCtD
Neostigmine—Syncope—Prednisone—prostate cancer	9.39e-05	0.000639	CcSEcCtD
Neostigmine—Tachycardia—Capecitabine—prostate cancer	9.37e-05	0.000637	CcSEcCtD
Neostigmine—Skin disorder—Capecitabine—prostate cancer	9.32e-05	0.000634	CcSEcCtD
Neostigmine—Urinary tract disorder—Epirubicin—prostate cancer	9.29e-05	0.000632	CcSEcCtD
Neostigmine—Hyperhidrosis—Capecitabine—prostate cancer	9.28e-05	0.000631	CcSEcCtD
Neostigmine—Hypotension—Docetaxel—prostate cancer	9.26e-05	0.00063	CcSEcCtD
Neostigmine—Connective tissue disorder—Epirubicin—prostate cancer	9.25e-05	0.000629	CcSEcCtD
Neostigmine—Urethral disorder—Epirubicin—prostate cancer	9.22e-05	0.000627	CcSEcCtD
Neostigmine—Loss of consciousness—Prednisone—prostate cancer	9.21e-05	0.000626	CcSEcCtD
Neostigmine—Nausea—Estradiol—prostate cancer	9.14e-05	0.000622	CcSEcCtD
Neostigmine—Vomiting—Mitoxantrone—prostate cancer	9.12e-05	0.00062	CcSEcCtD
Neostigmine—Convulsion—Prednisone—prostate cancer	9.07e-05	0.000617	CcSEcCtD
Neostigmine—Rash—Mitoxantrone—prostate cancer	9.04e-05	0.000615	CcSEcCtD
Neostigmine—Dermatitis—Mitoxantrone—prostate cancer	9.03e-05	0.000614	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Docetaxel—prostate cancer	9.03e-05	0.000614	CcSEcCtD
Neostigmine—Headache—Mitoxantrone—prostate cancer	8.98e-05	0.000611	CcSEcCtD
Neostigmine—Hypotension—Capecitabine—prostate cancer	8.97e-05	0.00061	CcSEcCtD
Neostigmine—Insomnia—Docetaxel—prostate cancer	8.96e-05	0.00061	CcSEcCtD
Neostigmine—Arthralgia—Prednisone—prostate cancer	8.92e-05	0.000606	CcSEcCtD
Neostigmine—Bradycardia—Doxorubicin—prostate cancer	8.86e-05	0.000603	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	8.86e-05	0.000602	CcSEcCtD
Neostigmine—Dyspnoea—Docetaxel—prostate cancer	8.84e-05	0.000601	CcSEcCtD
Neostigmine—Somnolence—Docetaxel—prostate cancer	8.81e-05	0.000599	CcSEcCtD
Neostigmine—Hypersensitivity—Etoposide—prostate cancer	8.79e-05	0.000598	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.74e-05	0.000595	CcSEcCtD
Neostigmine—Flushing—Epirubicin—prostate cancer	8.73e-05	0.000594	CcSEcCtD
Neostigmine—Insomnia—Capecitabine—prostate cancer	8.68e-05	0.00059	CcSEcCtD
Neostigmine—Urinary tract disorder—Doxorubicin—prostate cancer	8.6e-05	0.000585	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Docetaxel—prostate cancer	8.56e-05	0.000582	CcSEcCtD
Neostigmine—Asthenia—Etoposide—prostate cancer	8.56e-05	0.000582	CcSEcCtD
Neostigmine—Connective tissue disorder—Doxorubicin—prostate cancer	8.56e-05	0.000582	CcSEcCtD
Neostigmine—Dyspnoea—Capecitabine—prostate cancer	8.56e-05	0.000582	CcSEcCtD
Neostigmine—Anaphylactic shock—Prednisone—prostate cancer	8.55e-05	0.000581	CcSEcCtD
Neostigmine—Urethral disorder—Doxorubicin—prostate cancer	8.54e-05	0.00058	CcSEcCtD
Neostigmine—Nausea—Mitoxantrone—prostate cancer	8.52e-05	0.000579	CcSEcCtD
Neostigmine—Mediastinal disorder—Epirubicin—prostate cancer	8.48e-05	0.000577	CcSEcCtD
Neostigmine—Pruritus—Etoposide—prostate cancer	8.44e-05	0.000574	CcSEcCtD
Neostigmine—Shock—Prednisone—prostate cancer	8.41e-05	0.000572	CcSEcCtD
Neostigmine—Arrhythmia—Epirubicin—prostate cancer	8.41e-05	0.000572	CcSEcCtD
Neostigmine—Nervous system disorder—Prednisone—prostate cancer	8.38e-05	0.00057	CcSEcCtD
Neostigmine—Tachycardia—Prednisone—prostate cancer	8.34e-05	0.000567	CcSEcCtD
Neostigmine—Skin disorder—Prednisone—prostate cancer	8.3e-05	0.000565	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Capecitabine—prostate cancer	8.28e-05	0.000563	CcSEcCtD
Neostigmine—Hyperhidrosis—Prednisone—prostate cancer	8.26e-05	0.000562	CcSEcCtD
Neostigmine—Mental disorder—Epirubicin—prostate cancer	8.24e-05	0.000561	CcSEcCtD
Neostigmine—Diarrhoea—Etoposide—prostate cancer	8.16e-05	0.000555	CcSEcCtD
Neostigmine—Gastrointestinal pain—Docetaxel—prostate cancer	8.11e-05	0.000551	CcSEcCtD
Neostigmine—Flushing—Doxorubicin—prostate cancer	8.08e-05	0.00055	CcSEcCtD
Neostigmine—Flatulence—Epirubicin—prostate cancer	8.07e-05	0.000549	CcSEcCtD
Neostigmine—Dizziness—Etoposide—prostate cancer	7.89e-05	0.000536	CcSEcCtD
Neostigmine—Muscle spasms—Epirubicin—prostate cancer	7.88e-05	0.000536	CcSEcCtD
Neostigmine—Gastrointestinal pain—Capecitabine—prostate cancer	7.85e-05	0.000534	CcSEcCtD
Neostigmine—Mediastinal disorder—Doxorubicin—prostate cancer	7.85e-05	0.000534	CcSEcCtD
Neostigmine—Abdominal pain—Docetaxel—prostate cancer	7.84e-05	0.000533	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Prednisone—prostate cancer	7.79e-05	0.00053	CcSEcCtD
Neostigmine—Arrhythmia—Doxorubicin—prostate cancer	7.78e-05	0.000529	CcSEcCtD
Neostigmine—Insomnia—Prednisone—prostate cancer	7.73e-05	0.000526	CcSEcCtD
Neostigmine—Mental disorder—Doxorubicin—prostate cancer	7.63e-05	0.000519	CcSEcCtD
Neostigmine—Urticaria—Capecitabine—prostate cancer	7.62e-05	0.000518	CcSEcCtD
Neostigmine—Abdominal pain—Capecitabine—prostate cancer	7.59e-05	0.000516	CcSEcCtD
Neostigmine—Vomiting—Etoposide—prostate cancer	7.58e-05	0.000516	CcSEcCtD
Neostigmine—Agitation—Epirubicin—prostate cancer	7.53e-05	0.000512	CcSEcCtD
Neostigmine—Rash—Etoposide—prostate cancer	7.52e-05	0.000511	CcSEcCtD
Neostigmine—Dermatitis—Etoposide—prostate cancer	7.51e-05	0.000511	CcSEcCtD
Neostigmine—Headache—Etoposide—prostate cancer	7.47e-05	0.000508	CcSEcCtD
Neostigmine—Flatulence—Doxorubicin—prostate cancer	7.47e-05	0.000508	CcSEcCtD
Neostigmine—Syncope—Epirubicin—prostate cancer	7.35e-05	0.0005	CcSEcCtD
Neostigmine—Hypersensitivity—Docetaxel—prostate cancer	7.3e-05	0.000497	CcSEcCtD
Neostigmine—Muscle spasms—Doxorubicin—prostate cancer	7.29e-05	0.000496	CcSEcCtD
Neostigmine—Loss of consciousness—Epirubicin—prostate cancer	7.2e-05	0.00049	CcSEcCtD
Neostigmine—Asthenia—Docetaxel—prostate cancer	7.11e-05	0.000484	CcSEcCtD
Neostigmine—Convulsion—Epirubicin—prostate cancer	7.1e-05	0.000483	CcSEcCtD
Neostigmine—Nausea—Etoposide—prostate cancer	7.08e-05	0.000482	CcSEcCtD
Neostigmine—Hypersensitivity—Capecitabine—prostate cancer	7.07e-05	0.000481	CcSEcCtD
Neostigmine—Pruritus—Docetaxel—prostate cancer	7.01e-05	0.000477	CcSEcCtD
Neostigmine—Gastrointestinal pain—Prednisone—prostate cancer	6.99e-05	0.000475	CcSEcCtD
Neostigmine—Arthralgia—Epirubicin—prostate cancer	6.97e-05	0.000474	CcSEcCtD
Neostigmine—Agitation—Doxorubicin—prostate cancer	6.97e-05	0.000474	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	6.93e-05	0.000471	CcSEcCtD
Neostigmine—Asthenia—Capecitabine—prostate cancer	6.89e-05	0.000468	CcSEcCtD
Neostigmine—Dry mouth—Epirubicin—prostate cancer	6.82e-05	0.000464	CcSEcCtD
Neostigmine—Syncope—Doxorubicin—prostate cancer	6.8e-05	0.000462	CcSEcCtD
Neostigmine—Urticaria—Prednisone—prostate cancer	6.79e-05	0.000462	CcSEcCtD
Neostigmine—Pruritus—Capecitabine—prostate cancer	6.79e-05	0.000462	CcSEcCtD
Neostigmine—Diarrhoea—Docetaxel—prostate cancer	6.78e-05	0.000461	CcSEcCtD
Neostigmine—Abdominal pain—Prednisone—prostate cancer	6.76e-05	0.00046	CcSEcCtD
Neostigmine—Anaphylactic shock—Epirubicin—prostate cancer	6.69e-05	0.000455	CcSEcCtD
Neostigmine—Loss of consciousness—Doxorubicin—prostate cancer	6.66e-05	0.000453	CcSEcCtD
Neostigmine—Shock—Epirubicin—prostate cancer	6.58e-05	0.000447	CcSEcCtD
Neostigmine—Convulsion—Doxorubicin—prostate cancer	6.57e-05	0.000447	CcSEcCtD
Neostigmine—Diarrhoea—Capecitabine—prostate cancer	6.57e-05	0.000447	CcSEcCtD
Neostigmine—Nervous system disorder—Epirubicin—prostate cancer	6.56e-05	0.000446	CcSEcCtD
Neostigmine—Dizziness—Docetaxel—prostate cancer	6.55e-05	0.000446	CcSEcCtD
Neostigmine—Tachycardia—Epirubicin—prostate cancer	6.52e-05	0.000444	CcSEcCtD
Neostigmine—Skin disorder—Epirubicin—prostate cancer	6.49e-05	0.000442	CcSEcCtD
Neostigmine—Hyperhidrosis—Epirubicin—prostate cancer	6.46e-05	0.00044	CcSEcCtD
Neostigmine—Arthralgia—Doxorubicin—prostate cancer	6.45e-05	0.000439	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	6.41e-05	0.000436	CcSEcCtD
Neostigmine—Dizziness—Capecitabine—prostate cancer	6.35e-05	0.000432	CcSEcCtD
Neostigmine—Dry mouth—Doxorubicin—prostate cancer	6.31e-05	0.000429	CcSEcCtD
Neostigmine—Vomiting—Docetaxel—prostate cancer	6.3e-05	0.000429	CcSEcCtD
Neostigmine—Hypersensitivity—Prednisone—prostate cancer	6.3e-05	0.000428	CcSEcCtD
Neostigmine—Rash—Docetaxel—prostate cancer	6.25e-05	0.000425	CcSEcCtD
Neostigmine—Hypotension—Epirubicin—prostate cancer	6.25e-05	0.000425	CcSEcCtD
Neostigmine—Dermatitis—Docetaxel—prostate cancer	6.24e-05	0.000425	CcSEcCtD
Neostigmine—Headache—Docetaxel—prostate cancer	6.21e-05	0.000422	CcSEcCtD
Neostigmine—Anaphylactic shock—Doxorubicin—prostate cancer	6.19e-05	0.000421	CcSEcCtD
Neostigmine—Asthenia—Prednisone—prostate cancer	6.13e-05	0.000417	CcSEcCtD
Neostigmine—Vomiting—Capecitabine—prostate cancer	6.1e-05	0.000415	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.09e-05	0.000414	CcSEcCtD
Neostigmine—Shock—Doxorubicin—prostate cancer	6.09e-05	0.000414	CcSEcCtD
Neostigmine—Nervous system disorder—Doxorubicin—prostate cancer	6.07e-05	0.000413	CcSEcCtD
Neostigmine—Rash—Capecitabine—prostate cancer	6.05e-05	0.000412	CcSEcCtD
Neostigmine—Pruritus—Prednisone—prostate cancer	6.05e-05	0.000411	CcSEcCtD
Neostigmine—Insomnia—Epirubicin—prostate cancer	6.05e-05	0.000411	CcSEcCtD
Neostigmine—Dermatitis—Capecitabine—prostate cancer	6.05e-05	0.000411	CcSEcCtD
Neostigmine—Tachycardia—Doxorubicin—prostate cancer	6.04e-05	0.000411	CcSEcCtD
Neostigmine—Headache—Capecitabine—prostate cancer	6.01e-05	0.000409	CcSEcCtD
Neostigmine—Skin disorder—Doxorubicin—prostate cancer	6.01e-05	0.000409	CcSEcCtD
Neostigmine—Hyperhidrosis—Doxorubicin—prostate cancer	5.98e-05	0.000407	CcSEcCtD
Neostigmine—Dyspnoea—Epirubicin—prostate cancer	5.96e-05	0.000405	CcSEcCtD
Neostigmine—Somnolence—Epirubicin—prostate cancer	5.94e-05	0.000404	CcSEcCtD
Neostigmine—Nausea—Docetaxel—prostate cancer	5.89e-05	0.0004	CcSEcCtD
Neostigmine—Diarrhoea—Prednisone—prostate cancer	5.85e-05	0.000398	CcSEcCtD
Neostigmine—Hypotension—Doxorubicin—prostate cancer	5.78e-05	0.000393	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Epirubicin—prostate cancer	5.77e-05	0.000393	CcSEcCtD
Neostigmine—Nausea—Capecitabine—prostate cancer	5.7e-05	0.000388	CcSEcCtD
Neostigmine—Dizziness—Prednisone—prostate cancer	5.65e-05	0.000384	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.64e-05	0.000383	CcSEcCtD
Neostigmine—Insomnia—Doxorubicin—prostate cancer	5.59e-05	0.000381	CcSEcCtD
Neostigmine—Dyspnoea—Doxorubicin—prostate cancer	5.51e-05	0.000375	CcSEcCtD
Neostigmine—Somnolence—Doxorubicin—prostate cancer	5.5e-05	0.000374	CcSEcCtD
Neostigmine—Gastrointestinal pain—Epirubicin—prostate cancer	5.47e-05	0.000372	CcSEcCtD
Neostigmine—Vomiting—Prednisone—prostate cancer	5.43e-05	0.00037	CcSEcCtD
Neostigmine—Rash—Prednisone—prostate cancer	5.39e-05	0.000367	CcSEcCtD
Neostigmine—Dermatitis—Prednisone—prostate cancer	5.38e-05	0.000366	CcSEcCtD
Neostigmine—Headache—Prednisone—prostate cancer	5.36e-05	0.000364	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.34e-05	0.000363	CcSEcCtD
Neostigmine—Urticaria—Epirubicin—prostate cancer	5.31e-05	0.000361	CcSEcCtD
Neostigmine—Abdominal pain—Epirubicin—prostate cancer	5.28e-05	0.000359	CcSEcCtD
Neostigmine—Nausea—Prednisone—prostate cancer	5.08e-05	0.000345	CcSEcCtD
Neostigmine—Gastrointestinal pain—Doxorubicin—prostate cancer	5.06e-05	0.000344	CcSEcCtD
Neostigmine—Hypersensitivity—Epirubicin—prostate cancer	4.93e-05	0.000335	CcSEcCtD
Neostigmine—Urticaria—Doxorubicin—prostate cancer	4.91e-05	0.000334	CcSEcCtD
Neostigmine—Abdominal pain—Doxorubicin—prostate cancer	4.89e-05	0.000333	CcSEcCtD
Neostigmine—Asthenia—Epirubicin—prostate cancer	4.8e-05	0.000326	CcSEcCtD
Neostigmine—Pruritus—Epirubicin—prostate cancer	4.73e-05	0.000322	CcSEcCtD
Neostigmine—Diarrhoea—Epirubicin—prostate cancer	4.57e-05	0.000311	CcSEcCtD
Neostigmine—Hypersensitivity—Doxorubicin—prostate cancer	4.56e-05	0.00031	CcSEcCtD
Neostigmine—Asthenia—Doxorubicin—prostate cancer	4.44e-05	0.000302	CcSEcCtD
Neostigmine—Dizziness—Epirubicin—prostate cancer	4.42e-05	0.000301	CcSEcCtD
Neostigmine—Pruritus—Doxorubicin—prostate cancer	4.38e-05	0.000298	CcSEcCtD
Neostigmine—Vomiting—Epirubicin—prostate cancer	4.25e-05	0.000289	CcSEcCtD
Neostigmine—Diarrhoea—Doxorubicin—prostate cancer	4.23e-05	0.000288	CcSEcCtD
Neostigmine—Rash—Epirubicin—prostate cancer	4.22e-05	0.000287	CcSEcCtD
Neostigmine—Dermatitis—Epirubicin—prostate cancer	4.21e-05	0.000286	CcSEcCtD
Neostigmine—Headache—Epirubicin—prostate cancer	4.19e-05	0.000285	CcSEcCtD
Neostigmine—Dizziness—Doxorubicin—prostate cancer	4.09e-05	0.000278	CcSEcCtD
Neostigmine—Nausea—Epirubicin—prostate cancer	3.97e-05	0.00027	CcSEcCtD
Neostigmine—Vomiting—Doxorubicin—prostate cancer	3.93e-05	0.000267	CcSEcCtD
Neostigmine—Rash—Doxorubicin—prostate cancer	3.9e-05	0.000265	CcSEcCtD
Neostigmine—Dermatitis—Doxorubicin—prostate cancer	3.9e-05	0.000265	CcSEcCtD
Neostigmine—Headache—Doxorubicin—prostate cancer	3.88e-05	0.000264	CcSEcCtD
Neostigmine—Nausea—Doxorubicin—prostate cancer	3.67e-05	0.00025	CcSEcCtD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	2.37e-05	0.00037	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.37e-05	0.000369	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PLCB2—prostate cancer	2.36e-05	0.000368	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—LRP2—prostate cancer	2.36e-05	0.000368	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2C18—prostate cancer	2.36e-05	0.000368	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	2.35e-05	0.000366	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	2.34e-05	0.000365	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—P4HB—prostate cancer	2.32e-05	0.000361	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NCOA3—prostate cancer	2.32e-05	0.000361	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SULT2B1—prostate cancer	2.32e-05	0.000361	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MBTPS1—prostate cancer	2.32e-05	0.000361	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—RFK—prostate cancer	2.32e-05	0.000361	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NAGLU—prostate cancer	2.32e-05	0.000361	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AOX1—prostate cancer	2.32e-05	0.000361	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTM3—prostate cancer	2.32e-05	0.000361	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PGAM2—prostate cancer	2.32e-05	0.000361	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.28e-05	0.000355	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC22A1—prostate cancer	2.25e-05	0.000351	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—GNG5—prostate cancer	2.23e-05	0.000348	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.23e-05	0.000347	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HPGDS—prostate cancer	2.21e-05	0.000344	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	2.2e-05	0.000343	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SULT2A1—prostate cancer	2.2e-05	0.000342	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP2C19—prostate cancer	2.2e-05	0.000342	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AMACR—prostate cancer	2.2e-05	0.000342	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP3A43—prostate cancer	2.2e-05	0.000342	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SRD5A2—prostate cancer	2.2e-05	0.000342	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NAT1—prostate cancer	2.2e-05	0.000342	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—DEGS1—prostate cancer	2.2e-05	0.000342	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—LEP—prostate cancer	2.18e-05	0.000339	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	2.17e-05	0.000338	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MED12—prostate cancer	2.16e-05	0.000337	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GNG5—prostate cancer	2.14e-05	0.000334	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTT1—prostate cancer	2.14e-05	0.000334	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP2A6—prostate cancer	2.12e-05	0.00033	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—AKT1—prostate cancer	2.12e-05	0.00033	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.11e-05	0.000329	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	2.1e-05	0.000327	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HSD17B1—prostate cancer	2.09e-05	0.000326	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.08e-05	0.000324	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NCOA3—prostate cancer	2.07e-05	0.000322	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AKR1C3—prostate cancer	2.06e-05	0.000321	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PRKACB—prostate cancer	2.05e-05	0.000319	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.03e-05	0.000316	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP17A1—prostate cancer	2.03e-05	0.000316	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2e-05	0.000312	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	2e-05	0.000311	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HPGDS—prostate cancer	1.97e-05	0.000307	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2C19—prostate cancer	1.96e-05	0.000305	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—LEP—prostate cancer	1.94e-05	0.000303	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NCOA2—prostate cancer	1.93e-05	0.000301	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ACHE—prostate cancer	1.91e-05	0.000298	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTT1—prostate cancer	1.91e-05	0.000298	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.9e-05	0.000297	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	1.9e-05	0.000295	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2A6—prostate cancer	1.89e-05	0.000294	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.88e-05	0.000293	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	1.87e-05	0.000291	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—B4GALT4—prostate cancer	1.87e-05	0.000291	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HPGD—prostate cancer	1.87e-05	0.000291	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—INS—prostate cancer	1.86e-05	0.00029	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC5A5—prostate cancer	1.84e-05	0.000287	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	1.84e-05	0.000287	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AKR1C3—prostate cancer	1.84e-05	0.000286	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PRKACB—prostate cancer	1.83e-05	0.000285	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP17A1—prostate cancer	1.81e-05	0.000282	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	1.8e-05	0.000281	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP2E1—prostate cancer	1.8e-05	0.000281	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—IGF1—prostate cancer	1.8e-05	0.00028	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.8e-05	0.00028	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.78e-05	0.000278	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NQO1—prostate cancer	1.78e-05	0.000277	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—TH—prostate cancer	1.75e-05	0.000273	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—TNFRSF21—prostate cancer	1.75e-05	0.000273	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.74e-05	0.000272	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—MMP2—prostate cancer	1.74e-05	0.000271	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP3A4—prostate cancer	1.74e-05	0.000271	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.73e-05	0.000269	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NCOA2—prostate cancer	1.72e-05	0.000269	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.71e-05	0.000267	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP1B1—prostate cancer	1.71e-05	0.000266	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP7B1—prostate cancer	1.71e-05	0.000266	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MTAP—prostate cancer	1.71e-05	0.000266	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	1.71e-05	0.000266	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	1.67e-05	0.00026	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SULT1E1—prostate cancer	1.66e-05	0.000259	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SRD5A1—prostate cancer	1.66e-05	0.000259	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—INS—prostate cancer	1.66e-05	0.000259	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GGT1—prostate cancer	1.65e-05	0.000258	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC5A5—prostate cancer	1.64e-05	0.000256	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NCOA1—prostate cancer	1.63e-05	0.000254	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.63e-05	0.000253	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.61e-05	0.000251	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2E1—prostate cancer	1.61e-05	0.00025	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—IGF1—prostate cancer	1.61e-05	0.00025	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP19A1—prostate cancer	1.61e-05	0.00025	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NQO1—prostate cancer	1.59e-05	0.000247	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HSD17B3—prostate cancer	1.59e-05	0.000247	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ACSL4—prostate cancer	1.59e-05	0.000247	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.57e-05	0.000245	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.57e-05	0.000245	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—TH—prostate cancer	1.57e-05	0.000244	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.56e-05	0.000242	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—MMP2—prostate cancer	1.55e-05	0.000242	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP3A4—prostate cancer	1.55e-05	0.000241	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—RXRA—prostate cancer	1.55e-05	0.000241	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.54e-05	0.00024	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP1B1—prostate cancer	1.52e-05	0.000237	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PHGDH—prostate cancer	1.52e-05	0.000237	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ARG2—prostate cancer	1.52e-05	0.000237	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—UMPS—prostate cancer	1.52e-05	0.000237	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.51e-05	0.000236	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.51e-05	0.000235	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1.5e-05	0.000233	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—COMT—prostate cancer	1.49e-05	0.000232	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—LDHB—prostate cancer	1.49e-05	0.000232	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTP1—prostate cancer	1.49e-05	0.000231	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GGT1—prostate cancer	1.47e-05	0.00023	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP3A5—prostate cancer	1.46e-05	0.000228	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ITPR1—prostate cancer	1.46e-05	0.000228	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	1.46e-05	0.000227	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NCOA1—prostate cancer	1.45e-05	0.000226	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CXCL8—prostate cancer	1.45e-05	0.000226	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	1.44e-05	0.000224	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.44e-05	0.000224	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP19A1—prostate cancer	1.43e-05	0.000223	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	1.42e-05	0.000221	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PDHA1—prostate cancer	1.41e-05	0.00022	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—TCN2—prostate cancer	1.41e-05	0.00022	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA3—prostate cancer	1.41e-05	0.00022	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—UCP3—prostate cancer	1.41e-05	0.00022	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—RXRA—prostate cancer	1.38e-05	0.000215	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—TYMS—prostate cancer	1.38e-05	0.000215	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTM1—prostate cancer	1.36e-05	0.000213	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC22A3—prostate cancer	1.35e-05	0.00021	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HSD3B1—prostate cancer	1.35e-05	0.00021	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.34e-05	0.000209	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—LPL—prostate cancer	1.34e-05	0.000209	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CTNNB1—prostate cancer	1.34e-05	0.000208	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—COMT—prostate cancer	1.33e-05	0.000207	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTP1—prostate cancer	1.32e-05	0.000206	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.31e-05	0.000203	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ITPR1—prostate cancer	1.3e-05	0.000203	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.3e-05	0.000203	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP1A1—prostate cancer	1.29e-05	0.000202	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA4—prostate cancer	1.29e-05	0.000202	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—TBXAS1—prostate cancer	1.29e-05	0.000202	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CXCL8—prostate cancer	1.29e-05	0.000201	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ERCC2—prostate cancer	1.28e-05	0.0002	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.28e-05	0.0002	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.28e-05	0.000199	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA2—prostate cancer	1.26e-05	0.000196	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SULT1A1—prostate cancer	1.25e-05	0.000194	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ABCG5—prostate cancer	1.25e-05	0.000194	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—TYMS—prostate cancer	1.23e-05	0.000192	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTM1—prostate cancer	1.22e-05	0.00019	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA1—prostate cancer	1.22e-05	0.00019	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—MTHFR—prostate cancer	1.21e-05	0.000188	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.21e-05	0.000188	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HSD3B2—prostate cancer	1.2e-05	0.000187	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTO1—prostate cancer	1.2e-05	0.000187	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NAT2—prostate cancer	1.2e-05	0.000187	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—LPL—prostate cancer	1.2e-05	0.000186	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CTNNB1—prostate cancer	1.19e-05	0.000186	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPARA—prostate cancer	1.18e-05	0.000184	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP1A1—prostate cancer	1.15e-05	0.00018	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PLCB2—prostate cancer	1.15e-05	0.00018	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—LRP2—prostate cancer	1.15e-05	0.00018	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2C18—prostate cancer	1.15e-05	0.00018	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ERCC2—prostate cancer	1.14e-05	0.000178	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—P4HB—prostate cancer	1.13e-05	0.000176	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CAV1—prostate cancer	1.11e-05	0.000173	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.11e-05	0.000173	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC22A1—prostate cancer	1.1e-05	0.000171	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	1.1e-05	0.000171	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MTHFR—prostate cancer	1.08e-05	0.000168	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SULT2A1—prostate cancer	1.07e-05	0.000167	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.07e-05	0.000167	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.06e-05	0.000166	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPARA—prostate cancer	1.06e-05	0.000164	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MED12—prostate cancer	1.05e-05	0.000164	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GNG5—prostate cancer	1.05e-05	0.000163	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CG—prostate cancer	1.01e-05	0.000158	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NCOA3—prostate cancer	1.01e-05	0.000157	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CAV1—prostate cancer	9.92e-06	0.000155	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HPGDS—prostate cancer	9.62e-06	0.00015	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—INS—prostate cancer	9.59e-06	0.000149	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2C19—prostate cancer	9.55e-06	0.000149	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.48e-06	0.000148	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CREBBP—prostate cancer	9.4e-06	0.000146	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ACHE—prostate cancer	9.33e-06	0.000145	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTT1—prostate cancer	9.33e-06	0.000145	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2A6—prostate cancer	9.22e-06	0.000144	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	9.05e-06	0.000141	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CG—prostate cancer	9.04e-06	0.000141	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AKR1C3—prostate cancer	8.97e-06	0.00014	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PRKACB—prostate cancer	8.92e-06	0.000139	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CD—prostate cancer	8.91e-06	0.000139	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP17A1—prostate cancer	8.83e-06	0.000138	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	8.73e-06	0.000136	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—INS—prostate cancer	8.56e-06	0.000133	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NCOA2—prostate cancer	8.41e-06	0.000131	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NOS3—prostate cancer	8.41e-06	0.000131	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CREBBP—prostate cancer	8.38e-06	0.000131	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC5A5—prostate cancer	8.02e-06	0.000125	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CD—prostate cancer	7.95e-06	0.000124	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2E1—prostate cancer	7.84e-06	0.000122	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CB—prostate cancer	7.76e-06	0.000121	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NQO1—prostate cancer	7.75e-06	0.000121	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTGS2—prostate cancer	7.69e-06	0.00012	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—TH—prostate cancer	7.64e-06	0.000119	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP3A4—prostate cancer	7.56e-06	0.000118	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NOS3—prostate cancer	7.5e-06	0.000117	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP1B1—prostate cancer	7.43e-06	0.000116	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GGT1—prostate cancer	7.2e-06	0.000112	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NCOA1—prostate cancer	7.09e-06	0.00011	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP19A1—prostate cancer	6.99e-06	0.000109	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CB—prostate cancer	6.93e-06	0.000108	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTGS2—prostate cancer	6.86e-06	0.000107	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—RXRA—prostate cancer	6.74e-06	0.000105	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTEN—prostate cancer	6.71e-06	0.000105	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—COMT—prostate cancer	6.49e-06	0.000101	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTP1—prostate cancer	6.46e-06	0.000101	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—EP300—prostate cancer	6.4e-06	9.97e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ITPR1—prostate cancer	6.36e-06	9.91e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—TYMS—prostate cancer	6.01e-06	9.36e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTEN—prostate cancer	5.99e-06	9.33e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTM1—prostate cancer	5.94e-06	9.25e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—LPL—prostate cancer	5.83e-06	9.08e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—EP300—prostate cancer	5.71e-06	8.89e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP1A1—prostate cancer	5.63e-06	8.77e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ERCC2—prostate cancer	5.59e-06	8.7e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MTHFR—prostate cancer	5.25e-06	8.18e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARA—prostate cancer	5.15e-06	8.02e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CAV1—prostate cancer	4.84e-06	7.54e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CA—prostate cancer	4.73e-06	7.37e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CG—prostate cancer	4.41e-06	6.87e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CA—prostate cancer	4.22e-06	6.58e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—INS—prostate cancer	4.18e-06	6.51e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CREBBP—prostate cancer	4.09e-06	6.37e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CD—prostate cancer	3.88e-06	6.04e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AKT1—prostate cancer	3.87e-06	6.02e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NOS3—prostate cancer	3.66e-06	5.7e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AKT1—prostate cancer	3.45e-06	5.37e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CB—prostate cancer	3.38e-06	5.27e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGS2—prostate cancer	3.35e-06	5.22e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTEN—prostate cancer	2.92e-06	4.55e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—EP300—prostate cancer	2.79e-06	4.34e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CA—prostate cancer	2.06e-06	3.21e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AKT1—prostate cancer	1.68e-06	2.62e-05	CbGpPWpGaD
